MedTrace Logo

A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.

NCT06496893 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-07-11

No results posted yet for this study

Summary

A randomized, double-blind, placebo-controlled study to assess the effect of Glucocil® on metabolic health in individuals with prediabetes and Type 2 Diabetes Mellitus.

Conditions

  • Pre Diabetes
  • Type2 Diabetes Mellitus

Interventions

DIETARY_SUPPLEMENT

IP 1200 mg per soft gel capsule

Two soft gels to be taken with breakfast and two soft gels to be taken with dinner

DIETARY_SUPPLEMENT

Placebo Comparator: Placebo 1200 mg per soft gel capsule

Two soft gels to be taken with breakfast and two soft gels to be taken with dinner

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-25
Primary Completion
2024-12-25
Completion
2024-12-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06496893 on ClinicalTrials.gov